Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RGEGV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TWEAKR-KSPi-ADC2
|
|||||
| Synonyms |
TWEAKR-KSPi-ADC2
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 6 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
Colorectal cancer [ICD11:2B91]
Investigative
Endometrial cancer [ICD11:2C76]
Investigative
Glioblastoma [ICD11:2A00]
Investigative
Lung cancer [ICD11:2C25]
Investigative
Ovarian cancer [ICD11:2C73]
Investigative
|
|||||
| Antibody Name |
BAY-356
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A)
|
Antigen Info | ||||
| Payload Name |
KSP inhibitor
|
Payload Info | ||||
| Therapeutic Target |
Kinesin-like protein KIF11 (KIF11)
|
Target Info | ||||
| Linker Name |
Mc-peptide-based linker
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.